JD Supra

Protaryx Receives FDA Approval for Transseptal Puncture Device

Protaryx Medical, a Maryland-based company dedicated to “minimally invasive left-heart interventional therapies,” announced that its ...

Johnson & Johnson to Acquire Atraverse Medical in Cardiac Device Expansion

Johnson & Johnson (NYSE:JNJ) said on Friday it has agreed to acquire Atraverse Medical, Inc. , a privately held medical ...

New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures

Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today announced the publication of a new study ...
Investing.com Canada

Johnson & Johnson to acquire medical device firm Atraverse Medical

Johnson & Johnson (NYSE:JNJ) announced Friday it has entered into a definitive agreement to acquire Atraverse Medical, Inc., a privately-held medical device company that develops left-heart access and ...
TCTMD

ALONE-AF: Stopping OAC After Ablation Doesn’t Reduce Cognitive Function

CHICAGO, IL—When patients stop taking oral anticoagulation (OAC) after they’ve been free of atrial fibrillation (AF) ...
MassDevice

Johnson & Johnson launches head-to-head PFA trial pitting Varipulse against Boston Scientific’s Farapulse

Johnson & Johnson (NYSE:JNJ) today announced the initiation of a new trial evaluating competitive pulsed field ablation (PFA) ...